Synthetic compounds for treatment of inflammation
US6589975B2 · kind B2 · utility
5Cited by
10References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 5, 2002 |
| Grant date | Jul 8, 2003 |
| Priority date | — |
| Expiry date | Aug 5, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel uses of biologically active bis-heterocyclic e.g. bis-indole alkaloid compounds which have improved activity are disclosed. Pharmaceutical compositions containing the compounds are also disclosed. Specifically, the novel utility pertains to the anti-immunogenic and neurogenic inflammatory properties exhibited by the bis-indole compounds and their analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.